Myomo (MYO) Net Cash Flow Growth (1y) (2017 - 2025)
Powered by 
Analysis
Myomo (MYO) Net Cash Flow Growth (1y) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -562.77% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -9.88% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 83.30% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 2,827.78% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -395.56% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 168.38% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -593.75% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -103.49% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -54.17% |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -249.28% |
| Jun 30, 2025 | -1,455.79% |
| Mar 31, 2025 | -223.20% |
| Dec 31, 2024 | 29,127.52% |
| Sep 30, 2024 | 23.07% |
| Jun 30, 2024 | 112.73% |
| Mar 31, 2024 | -136.47% |
| Dec 31, 2023 | 97.07% |
| Sep 30, 2023 | 132.78% |
| Jun 30, 2023 | -20.60% |
| Mar 31, 2023 | 252.06% |
| Dec 31, 2022 | -171.43% |
| Sep 30, 2022 | -140.53% |
| Jun 30, 2022 | 24.95% |
| Mar 31, 2022 | -150.12% |
| Dec 31, 2021 | 359.14% |
| Sep 30, 2021 | -145.48% |
| Jun 30, 2021 | -20.24% |
| Mar 31, 2021 | -44.60% |
| Dec 31, 2020 | -923.88% |